drugset / Trial / NCT06481085
To Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a randomized, double-blind, placebo controlled, parallel group study, which aims to provide data on efficacy, safety and pharmacokinetics (PK) of multiple dose levels of HDM1002 tablets in adults with type 2 diabetes mellitus (T2DM) inadequately controlled on metformin and/or diet and exercise.
Timeline
- Start
- 2024-06-27
- Primary completion
- 2025-05-30
- Completion
- 2025-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HDM1002 | Unknown | 50 mg | Oral |
| Subject | HDM1002 | Unknown | 100 mg | Oral |
| Subject | HDM1002 | Unknown | 200 mg | Oral |
| Subject | HDM1002 | Unknown | 400 mg | Oral |